Stocks and Investing Stocks and Investing
Fri, May 29, 2020
Thu, May 28, 2020

Matthew Harrison Maintained (BLUE) at Hold with Increased Target to $73 on, May 28th, 2020


Published on 2024-10-27 07:16:26 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Increased Target from $69 to $73 on, May 28th, 2020.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $112 on, Tuesday, May 12th, 2020
  • Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Decreased Target to $70 on, Friday, March 27th, 2020
  • Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, February 3rd, 2020

Contributing Sources